ストックスクリーナーアプリを入手
2.32
8.41%
0.18
Traws Pharma Inc (TRAW) 最新ニュース
TRAW stock touches 52-week low at $2.01 amid sharp annual decline By Investing.com - Investing.com South Africa
Traws Pharma Reports 2024 Financial Results and Advances Bird Flu and COVID Programs - MSN
TRAW stock touches 52-week low at $2.01 amid sharp annual decline - Investing.com India
Traws Pharma Reports 2024 Results and Strategic Progress - TipRanks
Traws Pharma Showcases Promising COVID-19 Drug at ICAR Conference - MSN
Earnings call transcript: Traws Pharma Q1 2025 shows innovation boost By Investing.com - Investing.com South Africa
Earnings call transcript: Traws Pharma Q1 2025 shows innovation boost - Investing.com
Traws Pharma Announces Virtual Investor Event to Showcase Innovative Treatments for Bird Flu and COVID-19 - MSN
Traws Pharma Reports 2024 Financial Results and CEO Change - TipRanks
Traws Pharma CEO Werner Cautreels to retire - MSN
Traws Pharma Reports Full Year 2024 Results and Business Highlights - GlobeNewswire
Traws Pharma's Bird Flu Drug Shows Promise Despite $166M Annual LossKey Updates - Stock Titan
Traws Pharma (TRAW) Expected to Announce Quarterly Earnings on Monday - Defense World
Traws Pharma Announces CEO Transition as Werner Cautreels Retires - MSN
Traws Pharma announces CEO retirement and interim successor By Investing.com - Investing.com South Africa
Traws Pharma announces CEO retirement and interim successor - Investing.com India
Traws Pharma CEO Werner Cautreels Retires, Chair Iain Duke Succeeds on Interim Basis - MarketScreener
Traws Pharma Announces Management Updates - GlobeNewswire
Leadership Shift at Traws Pharma: Chairman Steps Up as CEO Exits, Key Antiviral Programs Continue - Stock Titan
Traws Pharma Reports Promising Preclinical Results for Bird Flu Treatment - MSN
Traws Pharma Announces Promising Data for Ratutrelvir as a COVID-19 Treatment - MSN
Traws Pharma to Host Investor Event on Bird Flu and COVID - GlobeNewswire
Former CDC Director Unveils Game-Changing Bird Flu and COVID Treatments at Traws Pharma Event - Stock Titan
Traws Pharma presents data on COVID-19 candidate ratutrelvir at ICAR - TipRanks
Traws Pharma’s ratutrelvir shows promise in COVID-19 treatment By Investing.com - Investing.com South Africa
Traws Pharma’s ratutrelvir shows promise in COVID-19 treatment - Investing.com
Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR - GlobeNewswire
Breakthrough: Next-Gen COVID Drug Defeats 18 Variants Without Ritonavir Boost - Stock Titan
Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates - GlobeNewswire
Breakthrough: New Bird Flu Drug Achieves Remarkable 99.9% Viral Reduction in Latest Primate Tests - Stock Titan
Traws Pharma Unveils Promising Bird Flu Treatment Data - MyChesCo
Traws Pharma touts bird flu drug efficacy at ICAR By Investing.com - Investing.com South Africa
Traws Pharma touts bird flu drug efficacy at ICAR - Investing.com
Traws Pharma Presents Positive Data For TXM As Bird Flu Treatment At ICAR -March 21, 2025 at 07:03 am EDT - Marketscreener.com
Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR - GlobeNewswire
Breakthrough: Revolutionary Bird Flu Drug Achieves Perfect Survival Rate in Latest Trial Data - StockTitan
Traws Pharma Enters $50 Million ATM Agreement With Citizens JMP Securities -March 10, 2025 at 05:35 pm EDT - Marketscreener.com
Traws Pharma Announces Promising Preclinical Results for Bird Flu Treatment - MSN
PA-based biopharma company reports positive results testing efficacy of bird flu antiviral - Pennsylvania Business Report
TRAW stock touches 52-week low at $2.14 amid sharp annual decline - Investing.com
Traws Pharma, Inc. (NASDAQ:TRAW) Short Interest Update - Defense World
Traws Pharma reports promising bird flu treatment results By Investing.com - Investing.com Canada
Traws Pharma reports promising bird flu treatment results - Investing.com India
Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil - GlobeNewswire
Can Traws Pharma's Single-Dose Treatment Combat the Growing Bird Flu Threat? - StockTitan
Traws Pharma Reports Positive Results From Accepted Bird Flu Model For Anti-Viral Candidate, Tivoxavir Marboxil - Marketscreener.com
Traws Pharma regains Nasdaq compliance - MSN
Soleno Therapeutics Reports 2024 Financial Results and Strategic Progress - MSN
2.00%
大文字化:
|
ボリューム (24 時間):